4.8 Article

Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in Melanoma

Journal

MOLECULAR CELL
Volume 40, Issue 5, Pages 841-849

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2010.11.020

Keywords

-

Funding

  1. National Institutes of Health (NIH) [AR043369]
  2. Melanoma Research Alliance
  3. Adelson Medical Research Foundation
  4. US-Israel Binational Science Foundation
  5. Doris Duke Medical Foundation
  6. American Cancer Society
  7. NRSA [NIH/NCI T32 CA070083]

Ask authors/readers for more resources

When it escapes early detection, malignant melanoma becomes a highly lethal and treatment-refractory cancer. Melastatin is greatly downregulated in metastatic melanomas and is widely believed to function as a melanoma tumor suppressor. Here we report that tumor suppressive activity is not mediated by melastatin but instead by a microRNA (miR-211) hosted within an intron of melastatin. Increasing expression of miR-211 but not melastatin reduced migration and invasion of malignant and highly invasive human melanomas characterized by low levels of melastatin and miR-211. An unbiased network analysis of melanoma-expressed genes filtered for their roles in metastasis identified three central node genes: IGF2R, TGFBR2, and NFAT5. Expression of these genes was reduced by miR-211, and knockdown of each gene phenocopied the effects of increased miR-211 on melanoma invasiveness. These data implicate miR-211 as a suppressor of melanoma invasion whose expression is silenced or selected against via suppression of the entire melastatin locus during human melanoma progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available